{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:11:18Z","timestamp":1784344278265,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T00:00:00Z","timestamp":1493510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ihj.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T13:31:14Z","timestamp":1502890274000},"page":"246-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine"],"prefix":"10.1016","volume":"70","author":[{"given":"Deep Chandh","family":"Raja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiridhar","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopali","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyendra","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2017.08.009_bib0005","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure","volume":"355","author":"Birks","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2017.08.009_bib0010","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/eurheartj\/ehn123","article-title":"Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the International VErapamil-SR\/trandolapril STudy (INVEST)","volume":"29","author":"Kolloch","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2017.08.009_bib0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2017.08.009_bib0020","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the american college of cardiology foundation\/American heart association task force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.009_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2125.2005.02544.x","article-title":"Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise","volume":"61","author":"Joannides","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ihj.2017.08.009_bib0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000073933","article-title":"A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction","volume":"100","author":"Manz","year":"2003","journal-title":"Cardiology"},{"key":"10.1016\/j.ihj.2017.08.009_bib0035","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/01.CIR.0000118464.48959.1C","article-title":"Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure","volume":"109","author":"Mulder","year":"2004","journal-title":"Circulation"},{"issue":"September (9641)","key":"10.1016\/j.ihj.2017.08.009_bib0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"issue":"September (9744)","key":"10.1016\/j.ihj.2017.08.009_bib0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"issue":"June (2)","key":"10.1016\/j.ihj.2017.08.009_bib0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ehj.2011.09.001","article-title":"Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure","volume":"63","author":"Mansour","year":"2011","journal-title":"Egypt Heart J"},{"issue":"August (5)","key":"10.1016\/j.ihj.2017.08.009_bib0055","first-page":"402","article-title":"Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?","volume":"11","author":"Rayan","year":"2011","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.ihj.2017.08.009_bib0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0002-8703(92)90986-6","article-title":"Assessment of patient outcome with the Minnesota living with heart failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group","volume":"124","author":"Rector","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2017.08.009_bib0065","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0002-9149(80)90122-8","article-title":"Noninvasive quantification of left ventricular wall stress: validation of method and application to the assessment of chronic pressure overload","volume":"45","author":"Quinones","year":"1980","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2017.08.009_bib0070","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/CIRCULATIONAHA.106.660639","article-title":"Myocardial energetics and efficiency: current status of the noninvasive approach","volume":"115","author":"Knaapen","year":"2007","journal-title":"Circulation"},{"issue":"February (2)","key":"10.1016\/j.ihj.2017.08.009_bib0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12325-015-0185-5","article-title":"Addition of ivabradine to \u03b2-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study","volume":"32","author":"Bagriy","year":"2015","journal-title":"Adv Ther"},{"issue":"September (2)","key":"10.1016\/j.ihj.2017.08.009_bib0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2011.06.098","article-title":"Effect of carvedilol, Ivabradine or their combination on exercise capacity in patients with heart failure (the CARVIVA HF trial)","volume":"151","author":"Volterrani","year":"2011","journal-title":"Int J Cardiol"},{"issue":"September (9)","key":"10.1016\/j.ihj.2017.08.009_bib0085","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s12325-014-0147-3","article-title":"Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice","volume":"31","author":"Zugck","year":"2014","journal-title":"Adv Ther"},{"issue":"October (20)","key":"10.1016\/j.ihj.2017.08.009_bib0090","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","article-title":"Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy","volume":"32","author":"Tardif","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2017.08.009_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/jpet.107.130237","article-title":"Effect of long-term heart rate reduction by I(f) current inhibition on pressure overload-induced heart failure in rats","volume":"324","author":"Ciobotaru","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ihj.2017.08.009_bib0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.amjcard.2007.11.023","article-title":"Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers","volume":"101","author":"Flannery","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2017.08.009_bib0105","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","article-title":"Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure","volume":"150","author":"McAlister","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483217302961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483217302961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T09:52:49Z","timestamp":1535449969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483217302961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0019483217302961"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2017.08.009","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}